These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 16020752)

  • 1. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells.
    Calnek DS; Mazzella L; Roser S; Roman J; Hart CM
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):52-7. PubMed ID: 12524224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
    Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J; Cook JA; O'Connor M; Zingarelli B
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production.
    Hwang J; Kleinhenz DJ; Lassègue B; Griendling KK; Dikalov S; Hart CM
    Am J Physiol Cell Physiol; 2005 Apr; 288(4):C899-905. PubMed ID: 15590897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
    Migita H; Morser J
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):710-6. PubMed ID: 15662020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
    Ray DM; Akbiyik F; Phipps RP
    J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
    Phulwani NK; Feinstein DL; Gavrilyuk V; Akar C; Kielian T
    J Neurochem; 2006 Dec; 99(5):1389-1402. PubMed ID: 17074064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
    Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM
    J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway.
    Ye F; Sun T; Luo H; Ding H; Chen K; Shen X; Jiang H
    Cell Physiol Biochem; 2006; 18(1-3):143-50. PubMed ID: 16914899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats.
    Lin TH; Yang RS; Tang CH; Lin CP; Fu WM
    Bone; 2007 Oct; 41(4):562-74. PubMed ID: 17669705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages.
    Piraino G; Cook JA; O'Connor M; Hake PW; Burroughs TJ; Teti D; Zingarelli B
    Shock; 2006 Aug; 26(2):146-53. PubMed ID: 16878022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo.
    Xin X; Yang S; Kowalski J; Gerritsen ME
    J Biol Chem; 1999 Mar; 274(13):9116-21. PubMed ID: 10085162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
    Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
    Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.